Cargando…
Cardamonin suppressed the migration, invasion, epithelial mesenchymal transition (EMT) and lung metastasis of colorectal cancer cells by down-regulating ADRB2 expression
CONTEXT: Cardamonin (CDN) can suppress cell growth in colorectal cancer (CRC), a common digestive malignancy. OBJECTIVE: We explored the effect and mechanism of CDN on metastatic CRC. MATERIALS AND METHODS: Two cell lines (HT29 and HCT116) were initially treated with CDN at different concentrations...
Autores principales: | Lu, Ting, Zheng, Chunju, Fan, Zhimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154753/ https://www.ncbi.nlm.nih.gov/pubmed/35645356 http://dx.doi.org/10.1080/13880209.2022.2069823 |
Ejemplares similares
-
Cardamonin Suppresses TGF-β1-Induced Epithelial Mesenchymal Transition via Restoring Protein Phosphatase 2A Expression
por: Kim, Eun Ji, et al.
Publicado: (2015) -
EFEMP2 Suppresses the Invasion of Lung Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition (EMT) and Down-Regulating MMPs
por: Song, Liang, et al.
Publicado: (2020) -
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021) -
SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration
por: Eguchi, Takanori, et al.
Publicado: (2022) -
Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)